AviadoBio Ltd. ("AviadoBio"), and UgeneX Therapeutics, today announced an exclusive option and license agreement for the development and commercialization of UGX-202, an investigational, AAV-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback